These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
270 related items for PubMed ID: 27276118
1. Diagnostic Quality of Magnetic Resonance Imaging Interpretation for Peripheral Nerve Sheath Tumors: Can Malignancy Be Determined? Karsy M, Guan J, Ravindra VM, Stilwill S, Mahan MA. J Neurol Surg A Cent Eur Neurosurg; 2016 Nov; 77(6):495-504. PubMed ID: 27276118 [Abstract] [Full Text] [Related]
2. Potential role of 18fluorodeoxyglucose-positron emission tomography/computed tomography in differentiating benign neurofibroma from malignant peripheral nerve sheath tumor associated with neurofibromatosis 1. Karabatsou K, Kiehl TR, Wilson DM, Hendler A, Guha A. Neurosurgery; 2009 Oct; 65(4 Suppl):A160-70. PubMed ID: 19927062 [Abstract] [Full Text] [Related]
3. Management of peripheral nerve sheath tumors: 17 years of experience at Toronto Western Hospital. Guha D, Davidson B, Nadi M, Alotaibi NM, Fehlings MG, Gentili F, Valiante TA, Tator CH, Tymianski M, Guha A, Zadeh G. J Neurosurg; 2018 Apr; 128(4):1226-1234. PubMed ID: 28686119 [Abstract] [Full Text] [Related]
11. Malignant peripheral nerve sheath tumors (MPNST) in neurofibromatosis type 1 (NF1): diagnostic findings on magnetic resonance images and mutation analysis of the NF1 gene. Friedrich RE, Kluwe L, Fünsterer C, Mautner VF. Anticancer Res; 2005 Apr; 25(3A):1699-702. PubMed ID: 16033085 [Abstract] [Full Text] [Related]
14. Diffusion-Weighted Magnetic Resonance Imaging Improves the Accuracy of Differentiation of Benign from Malignant Peripheral Nerve Sheath Tumors. Koike H, Nishida Y, Ito S, Shimoyama Y, Ikuta K, Urakawa H, Sakai T, Shimizu K, Ito K, Imagama S. World Neurosurg; 2022 Jan; 157():e207-e214. PubMed ID: 34624521 [Abstract] [Full Text] [Related]